Diebold Nixdorf, Incorporated (NYSE: DBD) last traded at $69.94, up 3.14% on the session. The quote above updates while this page is open; the figures below are drawn from Diebold Nixdorf, Incorporated’s own filings and are restated only when a new one is published.
Diebold Nixdorf, Incorporated trades on NYSE under the ticker DBD. Its market capitalisation is $2.37 billion.
Valuation measures for Diebold Nixdorf, Incorporated, derived from the latest quote and its most recent SEC filing.
| Market cap | $2.37B |
|---|---|
| Enterprise value | $4.78B |
| P/E ratio | 23.24 |
| Price / sales | 0.61 |
| Price / book | 2.45 |
| Beta | 1.21 |
Trailing-twelve-month figures tagged in Diebold Nixdorf, Incorporated's XBRL filings with the SEC.
| Revenue (TTM) | $3.87B |
|---|---|
| Net income (TTM) | $111.20M |
| EPS (TTM) | $3.01 |
| Gross margin | 25.25% |
| Operating margin | 6.36% |
| Return on equity | 11.47% |
| Cash | $358.60M |
Range and volume for DBD over the past 52 weeks.
| 52-week high | $92.09 |
|---|---|
| 52-week low | $54.48 |
| Volume | 173.6K |
| Average volume | 301.1K |
| Previous close | $67.81 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.